TY - JOUR
T1 - Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors
AU - Agrawal, Manasi
AU - Cohen-Mekelburg, Shirley
AU - Kayal, Maia
AU - Axelrad, Jordan
AU - Galati, Jonathan
AU - Tricomi, Brad
AU - Kamal, Kanika
AU - Faye, Adam S.
AU - Abrudescu, Paul
AU - Scherl, Ellen
AU - Lawlor, Garrett
AU - Sultan, Keith
AU - Lukin, Dana
AU - Colombel, Jean Frederic
AU - Ungaro, Ryan C.
N1 - Funding Information:
Funding information REDCap access was through support from the National Center For Advancing Translational Science of the National Institute of Health Under Award Number UL1TR002384. RCU is supported by a Career Development Award from the Crohn's and Colitis Foundation. Declaration of personal interest: None.
Funding Information:
REDCap access was through support from the National Center For Advancing Translational Science of the National Institute of Health Under Award Number UL1TR002384. RCU is supported by a Career Development Award from the Crohn's and Colitis Foundation.
Publisher Copyright:
© 2019 John Wiley & Sons Ltd
PY - 2019/3
Y1 - 2019/3
N2 - Background: Race, ethnicity and socio-economic status impact clinical outcomes in inflammatory bowel disease (IBD) patients. However, their impact on disability has not been studied. Aim: To determine the association between race, ethnicity and socio-economic factors with disability in IBD, using the validated IBD disability index (IBD-DI). Methods: Ambulatory IBD patients were enrolled at five academic centres participating in the New York Crohn's and Colitis Organization. We assessed the IBD-DI, and collected clinical and socio-economic data. Factors associated with moderate-to-severe disability (IBD-DI score > 35) on univariable analysis were tested in multivariable models with adjusted odds ratios (aOR) and 95% confidence intervals (CI) reported. Results: In this study, 323 patients (57.3% CD, 51.4% female) were enrolled; 17.7% were Hispanic, 17% were non-Hispanic black, 56.0% were non-Hispanic Caucasian and 9.3% belonged to non-Hispanic non-black minority races. However, 39.0% of patients were publicly insured and 38.4% of patients had low annual household income (<$50 000). 100 (31.0%) patients reported moderate-to-severe disability. On multivariable analysis, Hispanic ethnicity (aOR 2.7, 95% CI 1.3-5.6), non-Hispanic non-black minority race (aOR 3.5, 95% CI 1.3-8.9), public payer (aOR 2.1, 95% CI 1.1-4.0) and low annual household income (aOR 3.0, 95% CI 1.7-5.4) were associated with moderate-to-severe disability controlling for disease characteristics. Conclusions: IBD patients who are minorities, have public insurance, or low household income, are 2-3 times more likely to report moderate-to-severe disability independent of disease characteristics in the United States. Future studies are needed to study their complex relationship and to mitigate disability.
AB - Background: Race, ethnicity and socio-economic status impact clinical outcomes in inflammatory bowel disease (IBD) patients. However, their impact on disability has not been studied. Aim: To determine the association between race, ethnicity and socio-economic factors with disability in IBD, using the validated IBD disability index (IBD-DI). Methods: Ambulatory IBD patients were enrolled at five academic centres participating in the New York Crohn's and Colitis Organization. We assessed the IBD-DI, and collected clinical and socio-economic data. Factors associated with moderate-to-severe disability (IBD-DI score > 35) on univariable analysis were tested in multivariable models with adjusted odds ratios (aOR) and 95% confidence intervals (CI) reported. Results: In this study, 323 patients (57.3% CD, 51.4% female) were enrolled; 17.7% were Hispanic, 17% were non-Hispanic black, 56.0% were non-Hispanic Caucasian and 9.3% belonged to non-Hispanic non-black minority races. However, 39.0% of patients were publicly insured and 38.4% of patients had low annual household income (<$50 000). 100 (31.0%) patients reported moderate-to-severe disability. On multivariable analysis, Hispanic ethnicity (aOR 2.7, 95% CI 1.3-5.6), non-Hispanic non-black minority race (aOR 3.5, 95% CI 1.3-8.9), public payer (aOR 2.1, 95% CI 1.1-4.0) and low annual household income (aOR 3.0, 95% CI 1.7-5.4) were associated with moderate-to-severe disability controlling for disease characteristics. Conclusions: IBD patients who are minorities, have public insurance, or low household income, are 2-3 times more likely to report moderate-to-severe disability independent of disease characteristics in the United States. Future studies are needed to study their complex relationship and to mitigate disability.
UR - http://www.scopus.com/inward/record.url?scp=85060333670&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060333670&partnerID=8YFLogxK
U2 - 10.1111/apt.15107
DO - 10.1111/apt.15107
M3 - Article
C2 - 30663075
AN - SCOPUS:85060333670
SN - 0269-2813
VL - 49
SP - 564
EP - 571
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
IS - 5
ER -